Sunscreens - What's important to know

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 9, 2008, Pages 1110-1119

  Antoniou, C ^a   Kosmadaki, M G ^a   Stratigos, A J ^a   Katsambas, A D ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Photoprotection; Sunscreens; UVA; UVB

Indexed keywords

4 AMINOBENZOIC ACID; 4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; ANISOTRIAZINE; AVOBENZONE; BENZOPHENONE DERIVATIVE; BISETHYLHEXYLOXYPHENOLMETHOXYPHENOLTRIAZINE; CINNAMIC ACID DERIVATIVE; DIBENZOYLMETHANE DERIVATIVE; DIETHYLAMINOHYDROXYBENZOYLHEXYLBENZOATE; DROMETRIAZOLE TRISILOXANE; DROMETRIZOLE TRISULPHONIC; ETHYLHEXYLMETHOXYCINNAMATE; HOMOSALATE; METHYLENE BISBENZOTRIAZOLYLTETRAMETHYLBUTYLPHENOL; METHYLENEBISBENZOTRIAZOLTETRAMETHYLBUTYLPHENOL; MEXORYL SX; MEXORYL XL; NANOPARTICLE; OCTISALATE; OCTYLDIMETHYL 4 AMINOBENZOIC ACID; OXYBENZONE; OXYBENZOPHENONE; SALICYLIC ACID DERIVATIVE; SALICYLIC ACID OCTYL ESTER; SUNSCREEN; TEREPHTHALYDENEDICAMPHORSULFONIC ACID; TINASORB M; TINASORB S; TITANIUM DIOXIDE; UNCLASSIFIED DRUG; ZINC OXIDE;

ALLERGIC REACTION; CANCER PREVENTION; CONTACT ALLERGY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG PENETRATION; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MELANOMA; MICROENCAPSULATION; NONHUMAN; PHOTOALLERGY; PHOTODERMATOSIS; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION PROTECTION; REVIEW; SKIN ABSORPTION; SKIN IRRITATION; SUN EXPOSURE; SUNBURN; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET IRRADIATION;

HUMANS; MELANOMA; SKIN NEOPLASMS; SUNSCREENING AGENTS; ULTRAVIOLET RAYS;

EID: 49649127404     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02580.x     Document Type: Review

References (74)

1. Bruls WA, Slaper H, van der Leun JC et al. Transmission of human epidermis and stratum corneum as a function of thickness in the ultraviolet and visible wavelengths. Photochem Photobiol 1984 40 : 485 494.
2. Cadet J, Sage E, Douki T. Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res 2005 571 : 3 17.
3. De Fabo EC, Noonan FP. Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology. J Exp Med 1983 158 : 84 98.
4. Heck DE, Vetrano AM, Mariano TM, Laskin JD. UVB light stimulates production of reactive oxygen species: unexpected role for catalase. J Biol Chem 2003 278 : 22432 22436.
5. Strickland PT. Photocarcinogenesis by near-ultraviolet (UVA) radiation in Sencar mice. J Invest Dermatol 1986 87 : 272 275.
6. Sterenborg HJ, van der Leun JC. Tumorigenesis by a long wavelength UV-A source. Photochem Photobiol 1990 51 : 325 330.
7. Agar NS, Halliday GM, Barnetson RS, Ananthaswamy HN, Wheeler M, Jones AM. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc Natl Acad Sci USA 2004 101 : 4954 4959.
8. Mouret S, Baudouin C, Charveron M, Favier A, Cadet J, Douki T. Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation. Proc Natl Acad Sci U S A 2006 103 : 13765 13770.
9. Kappes UP, Luo D, Potter M, Schulmeister K, Runger M. Short- and long-wave UV light (UVB and UVA) induce similar mutations in human skin cells. J Invest Dermatol 2006 126 : 667 675.
10. Dumay O, Karam A, Vian L et al. Ultraviolet AI exposure of human skin results in Langerhans cell depletion and reduction of epidermal antigen-presenting cell function: partial protection by a broad-spectrum sunscreen. Br J Dermatol 2001 144 : 1161 1168.
11. Schwarz T. Mechanisms of UV-induced immunosuppression. Keio J Med 2005 54 : 165 171.
12. Krutmann J. Ultraviolet A radiation-induced biological effects in human skin: relevance for photoaging and photodermatosis. J Dermatol Sci 2000 23 (Suppl. 1 S22 S26.
13. Liardet S, Scaletta C, Panizzon R et al. Protection against pyrimidine dimers, p53, and 8-hydroxy-2′-deoxyguanosine expression in ultraviolet-irradiated human skin by sunscreens: difference between UVB + UVA and UVB alone sunscreens. J Invest Dermatol 2001 117 : 1437 1441.
14. Whitmore SE, Morison WL. Prevention of UVB-induced immunosuppression in humans by a high sun protection factor sunscreen. Arch Dermatol 1995 131 : 1128 1133.
15. Seite S, Colige A, Piquemal-Vivenot P et al. A full-UV spectrum absorbing daily use cream protects human skin against biological changes occurring in photoaging. Photodermatol Photoimmunol Photomed 2000 16 : 147 155.
16. Roelandts R. Shedding light on sunscreens. Clin Exp Dermatol 1998 23 : 147 157.
17. Gasparro FP, Mitchnick M, Nash JF. A review of sunscreen safety and efficacy. Photochem Photobiol 1998 68 : 243 256.
18. Moloney FJ, Collins S, Murphy GM. Sunscreens: safety, efficacy and appropriate use. Am J Clin Dermatol 2002 3 : 185 191.
19. Walters KA, Brain KR, Howes D et al. Percutaneous penetration of octyl salicylate from representative sunscreen formulations through human skin in vitro. Food Chem Toxicol 1997 35 : 1219 1225.
20. Fisher AA. Sunscreen dermatitis: Part II - The cinnamates. Cutis 1992 50 : 253 254.
21. Thune P. Contact and photocontact allergy to sunscreens. Photodermatol 1984 1 : 5 9.
22. Darvay A, White IR, Rycroft RJ, Jones AB, Hawk JL, McFadden JP. Photoallergic contact dermatitis is uncommon. Br J Dermatol 2001 145 : 597 601.
23. Perugini P, Simeoni S, Scalia S et al. Effect of nanoparticle encapsulation on the photostability of the sunscreen agent, 2-ethylhexyl-p- methoxycinnamate. Int J Pharm 2002 246 : 37 45.
24. de Freitas ZM, dos Santos EP, da Rocha JF, Dellamora-Ortiz GM, Goncalves JC. A new sunscreen of the cinnamate class: synthesis and enzymatic hydrolysis evaluation of glyceryl esters of p-methoxycinnamic acid. Eur J Pharm Sci 2005 25 : 67 72.
25. Janjua NR, Mogensen B, Andersson AM et al. Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J Invest Dermatol 2004 123 : 57 61.
26. Gustavsson Gonzalez H, Farbrot A, Larko O. Percutaneous absorption of benzophenone-3, a common component of topical sunscreens. Clin Exp Dermatol 2002 27 : 691 694.
27. Hayden CG, Roberts MS, Benson HA. Systemic absorption of sunscreen after topical application. Lancet 1997 350 : 863 864.
28. Benson HA. Assessment and clinical implications of absorption of sunscreens across skin. Am J Clin Dermatol 2000 1 : 217 224.
29. Schauder S, Ippen H. Contact and photocontact sensitivity to sunscreens. Review of a 15-year experience and of the literature. Contact Dermatitis 1997 37 : 221 232.
30. Weigmann HJ, Lademann J, Schanzer S et al. Correlation of the local distribution of topically applied substances inside the stratum corneum determined by tape-stripping to differences in bioavailability. Skin Pharmacol Appl Skin Physiol 2001 14 (Suppl. 1 98 102.
31. Simeoni S, Scalia S, Benson HA. Influence of cyclodextrins on in vitro human skin absorption of the sunscreen, butyl-methoxydibenzoylmethane. Int J Pharm 2004 280 : 163 171.
32. Benech-Kieffer F, Meuling WJ, Leclerc C, Roza L, Leclaire J, Nohynek G. Percutaneous absorption of Mexoryl SX in human volunteers: comparison with in vitro data. Skin Pharmacol Appl Skin Physiol 2003 16 : 343 355.
33. Hughes TM, Martin JA, Lewis VJ, Stone NM. Allergic contact dermatitis to drometrizole trisiloxane in a sunscreen with concomitant sensitivities to other sun screens. Contact Dermatitis 2005 52 : 226 227.
34. Gonzalez-Perez R, Trebol I, Garcia-Rio I, Arrequi MA, Soloeta R. Allergic contact dermatitis from methylene-bis-benzotriazolyl tetramethylbutylphenol (Tinosorb M). Contact Dermatitis 2007 56 : 121.
35. Chatelain E, Gabard B. Photostabilization of butyl methoxydibenzoylmethane (Avobenzone) and ethylhexyl methoxycinnamate by bis-ethylhexyloxyphenol methoxyphenyl triazine (Tinosorb S), a new UV broadband filter. Photochem Photobiol 2001 74 : 401 406.
36. Tan MH, Commens CA, Burnett L, Snitch PJ. A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens. Australas J Dermatol 1996 37 : 185 187.
37. Agren MS. Percutaneous absorption of zinc from zinc oxide applied topically to intact skin in man. Dermatologica 1990 180 : 36 39.
38. Schulz J, Hohenberg H, Pflucker F et al. Distribution of sunscreens on skin. Adv Drug Deliv Rev 2002 54 (Suppl. 1 S157 S163.
39. Derry JE, McLean WM, Freeman JB. A study of the percutaneous absorption from topically applied zinc oxide ointment. JPEN J Parenter Enteral Nutr 1983 7 : 131 135.
40. Gogna D, Jain SK, Yadav AK, Agrawal GP. Microsphere based improved sunscreen formulation of ethylhexyl methoxycinnamate. Curr Drug Deliv 2007 4 : 153 159.
41. Patel M, Jain SK, Yadav AK, Gogna D, Agrawal GP. Preparation and characterization of oxybenzone-loaded gelatin microspheres for enhancement of sunscreening efficacy. Drug Deliv 2006 13 : 323 330.
42. Lavker RM, Gerberick GF, Veres D, Irwin CJ, Kaidbey KH. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin. J Am Acad Dermatol 1995 32 : 53 62.
43. Diffey B. A method for broad spectrum classification of sunscreens. Int J Cosm Sci 1994 16 : 47 52.
44. Fourtanier A, Moyal D, Maccario J et al. Measurement of sunscreen immune protection factors in humans: a consensus paper. J Invest Dermatol 2005 125 : 403 409.
45. Young AR. Methods used to evaluate the immune protection factor of a sunscreen: advantages and disadvantages of different in vivo techniques. Cutis 2004 74 : 19 23.
46. Young AR. Are broad-spectrum sunscreens necessary for immunoprotection? J Invest Dermatol 2003 121 : ix x.
47. Kelly DA, Seed PT, Young AR, Walker SL. A commercial sunscreen's protection against ultraviolet radiation-induced immunosuppression is more than 50% lower than protection against sunburn in humans. J Invest Dermatol 2003 120 : 65 71.
48. Maier H, Schauberger G, Brunnhofer K, Honigsmann H. Change of ultraviolet absorbance of sunscreens by exposure to solar-simulated radiation. J Invest Dermatol 2001 117 : 256 262.
49. Rodenas JM, Delgado-Rodriguez M, Herranz MT, Tercedor J, Serrano S. Sun exposure, pigmentary traits, and risk of cutaneous malignant melanoma: a case-control study in a Mediterranean population. Cancer Causes Control 1996 7 : 275 283.
50. Espinosa Arranz J, Sanchez Hernandez JJ, Bravo Fernandez P et al. Cutaneous malignant melanoma and sun exposure in Spain. Melanoma Res 1999 9 : 199 205.
51. Bakos L, Wagner M, Bakos RM et al. Sunburn, sunscreens, and phenotypes: some risk factors for cutaneous melanoma in southern Brazil. Int J Dermatol 2002 41 : 557 562.
52. Westerdahl J, Olsson H, Masback A, Ingvar C, Jonsson N. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res 1995 5 : 59 65.
53. Westerdahl J, Ingvar C, Masback A, Olsson H. Sunscreen use and malignant melanoma. Int J Cancer 2000 87 : 145 150.
54. Autier P, Dore JF, Schifflers E et al. Melanoma and use of sunscreens: an Eortc case-control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group Int J Cancer 1995 61 : 749 755.
55. Huncharek M, Kupelnick B. Use of topical sunscreens and the risk of malignant melanoma: a meta-analysis of 9067 patients from 11 case-control studies. Am J Public Health 2002 92 : 1173 1177.
56. Dennis LK, Beane Freeman LE, VanBeek MJ. Sunscreen use and the risk for melanoma: a quantitative review. Ann Intern Med 2003 139 : 966 978.
57. Bastuji-Garin S, Diepgen TL. Cutaneous malignant melanoma, sun exposure, and sunscreen use: epidemiological evidence. Br J Dermatol 2002 146 (Suppl. 61 24 30.
58. Rigel DS. The effect of sunscreen on melanoma risk. Dermatol Clin 2002 20 : 601 606.
59. Weinstock MA. Do sunscreens increase or decrease melanoma risk: an epidemiologic evaluation. J Invest Dermatol Symp Proc 1999 4 : 97 100.
60. Rosenstein BS, Phelps RG, Weinstock MA et al. p53 mutations in basal cell carcinomas arising in routine users of sunscreens. Photochem Photobiol 1999 70 : 798 806.
61. Ananthaswamy HN, Ullrich SE, Kripke ML. Inhibition of UV-induced p53 mutations and skin cancers by sunscreens: implication for skin cancer prevention. Exp Dermatol 2002 11 (Suppl. 1 40 43.
62. Miyagi T, Bhutto AM, Nonaka S. The effects of sunscreens on UVB erythema and Langerhans cell depression. J Dermatol 1994 21 : 645 651.
63. Bauer J, Buttner P, Wiecker TS, Luther H, Garbe C. Effect of sunscreen and clothing on the number of melanocytic nevi in 1812 German children attending day care. Am J Epidemiol 2005 161 : 620 627.
64. Lee TK, Rivers JK, Gallagher RP. Site-specific protective effect of broad-spectrum sunscreen on nevus development among white schoolchildren in a randomized trial. J Am Acad Dermatol 2005 52 : 786 792.
65. English DR, Milne E, Jacoby P, Giles-Corti B, Cross D, Johnston R. The effect of a school-based sun protection intervention on the development of melanocytic nevi in children: 6-year follow-up. Cancer Epidemiol Biomarkers Prev 2005 14 : 977 980.
66. Holly EA, Kelly JW, Shpall SN et al. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987 17 : 459 468.
67. Fitzgerald LM, Fryer JL, Dwyer T et al. Effect of MELANOTAN, [Nle(4), D-Phe(7)]-alpha-MSH, on melanin synthesis in humans with MC1R variant alleles. Peptides 2006 27 : 388 394.
68. Barnetson RS, Ooi TK, Zhuang L et al. [Nle4-D-Phe7]-alpha-melanocyte- stimulating hormone significantly increased pigmentation and decreased UV damage in fair-skinned Caucasian volunteers. J Invest Dermatol 2006 126 : 1869 1878.
69. Hadley ME, Sharma SD, Hruby VJ et al. Melanotropic peptides for therapeutic and cosmetic tanning of the skin. Ann N Y Acad Sci 1993 680 : 424 439.
70. Levine N, Sheftel SN, Eytan T et al. Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. Jama 1991 266 : 2730 2736.
71. Yarosh D, Klein J, O'Connor A et al. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group Lancet 2001 357 : 926 929.
72. Wolf P, Cox P, Yarosh DB et al. Sunscreens and T4N5 liposomes differ in their ability to protect against ultraviolet-induced sunburn cell formation, alterations of dendritic epidermal cells, and local suppression of contact hypersensitivity. J Invest Dermatol 1995 104 : 287 292.
73. Gilchrest BA, Eller MS. The tale of the telomere: implications for prevention and treatment of skin cancers. J Invest Dermatol Symp Proc 2005 10 : 124 130.
74. Kosmadaki MG, Gilchrest BA. The role of telomeres in skin aging/photoaging. Micron 2004 35 : 155 159.